{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:57:13Z","timestamp":1740149833833,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12328-021-01524-1","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T08:14:50Z","timestamp":1634631290000},"page":"1725-1732","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Successful treatment of Japanese hemophilia patient co-infected with HIV and HCV genotype 4a by glecaprevir\/pibrentasvir therapy"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3202-7983","authenticated-orcid":false,"given":"Ken","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kanayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Tojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Suga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Kakizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Uraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"1524_CR1","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","volume":"394","author":"CW Spearman","year":"2019","unstructured":"Spearman CW, Dusheiko GM, Hellard M, et al. Hepatitis C. Lancet. 2019;394:1451\u201366.","journal-title":"Lancet"},{"key":"1524_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","volume":"2","author":"Polaris Observatory HCV Collaborators","year":"2017","unstructured":"Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2:161\u201376.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1524_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1386-6346(03)00016-0","volume":"25","author":"K Hayashi","year":"2003","unstructured":"Hayashi K, Fukuda Y, Nakano I, et al. Prevalence and characterization of hepatitis C virus genotype 4 in Japanese hepatitis C carriers. Hepatol Res. 2003;25:409\u201314.","journal-title":"Hepatol Res"},{"key":"1524_CR4","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.2169\/internalmedicine.6728-20","volume":"60","author":"M Totsuka","year":"2021","unstructured":"Totsuka M, Honda M, Kanda T, et al. Japanese man with HCV genotype 4 infection and cirrhosis who was successfully treated by the combination of glecaprevir and pibrentasvir. Intern Med. 2021;60:2061\u20136.","journal-title":"Intern Med"},{"key":"1524_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/QAI.0000000000001271","volume":"74","author":"A Nagao","year":"2017","unstructured":"Nagao A, Hanabusa H. Brief report: the impact of ledipasvir\/sofosbuvir on HIV-positive and HIV-negative Japanese hemophilia patients with 1, 4, and mixed-genotype HCV. J Acquir Immune Defic Syndr. 2017;74:418\u201322.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1524_CR6","doi-asserted-by":"publisher","first-page":"e0186255","DOI":"10.1371\/journal.pone.0186255","volume":"12","author":"H Uemura","year":"2017","unstructured":"Uemura H, Tsukada K, Mizushima D, et al. Interferon-free therapy with direct acting antivirals for HCV\/HIV-1 co-infected Japanese patients with inherited bleeding disorders. PLoS ONE. 2017;12:e0186255.","journal-title":"PLoS ONE"},{"key":"1524_CR7","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.7132-21","author":"M Minemura","year":"2021","unstructured":"Minemura M, Tajiri K, Hayashi Y, et al. Discrepant diagnostic results of nested polymerase chain reaction-based genotyping in a patient with hepatitis C virus and human immunodeficiency virus co-infection. Intern Med. 2021. https:\/\/doi.org\/10.2169\/internalmedicine.7132-21.","journal-title":"Intern Med"},{"key":"1524_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2957\/kanzo.57.447","volume":"57","author":"T Aikawa","year":"2016","unstructured":"Aikawa T, Tsuda F, Ueno C, et al. Comparison of test results of serogrouping and core region PCR-based genotyping in patients with chronic hepatitis C virus infection: Analysis of indeterminate or discrepant cases and identification of a 2b\/1b recombinant HCV. Kanzo. 2016;57:447\u201356.","journal-title":"Kanzo."},{"key":"1524_CR9","unstructured":"Interview form of Maviret co-formulation, 7th edn. 2020; 63 ((In Japanese)). https:\/\/a-connect.abbvie.co.jp\/-\/media\/assets\/pdf\/products\/maviret\/if_Maviret_j.pdf Accessed 20 July 2021."},{"key":"1524_CR10","unstructured":"Interview form of Maviret co-formulation, 7th edn. 2019; 66 ((In Japanese)). https:\/\/a-connect.abbvie.co.jp\/-\/media\/assets\/pdf\/products\/maviret\/if_Maviret_j.pdf Accessed 20 July 2021."},{"issue":"Suppl 1","key":"1524_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/jth.15189","volume":"19","author":"CRM Hay","year":"2021","unstructured":"Hay CRM, Nissen F, Pipe SW. Mortality in congenital hemophilia A\u2014a systematic literature review. J Thromb Haemost. 2021;19(Suppl 1):6\u201320.","journal-title":"J Thromb Haemost"},{"key":"1524_CR12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1473-3099(15)70099-X","volume":"15","author":"M Mizokami","year":"2015","unstructured":"Mizokami M, Yokosuka O, Takehara T, et al. Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial. Lancet Infect Dis. 2015;15:645\u201353.","journal-title":"Lancet Infect Dis"},{"key":"1524_CR13","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/S1473-3099(17)30496-6","volume":"17","author":"X Forns","year":"2017","unstructured":"Forns X, Lee SS, Valdes J, et al. Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial. Lancet Infect Dis. 2017;17:1062\u20138.","journal-title":"Lancet Infect Dis"},{"key":"1524_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jhep.2019.10.020","volume":"72","author":"RS Brown Jr","year":"2020","unstructured":"Brown RS Jr, Buti M, Rodrigues L, et al. Glecaprevir\/pibrentasvir for 8 weeks in treatment-na\u00efve patients with chronic HCV genotypes 1\u20136 and compensated cirrhosis: the EXPEDITION-8 trial. J Hepatol. 2020;72:441\u20139.","journal-title":"J Hepatol"},{"key":"1524_CR15","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/cid\/ciy220","volume":"67","author":"JK Rockstroh","year":"2018","unstructured":"Rockstroh JK, Lacombe K, Viani RM, et al. Efficacy and safety of glecaprevir\/pibrentasvir in patients co-infected with hepatitis C virus and human immunodeficiency virus type 1: the EXPEDITION-2 study. Clin Infect Dis. 2018;67:1010\u20137.","journal-title":"Clin Infect Dis"},{"key":"1524_CR16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s00535-017-1396-0","volume":"53","author":"H Kumada","year":"2018","unstructured":"Kumada H, Watanabe T, Suzuki F, et al. Efficacy and safety of glecaprevir\/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection. J Gastroenterol. 2018;53:566\u201375.","journal-title":"J Gastroenterol"},{"key":"1524_CR17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2169\/internalmedicine.1856-18","volume":"58","author":"T Sho","year":"2019","unstructured":"Sho T, Suda G, Kimura M, et al. Glecaprevir and pibrentasvir for Japanese patients with human immunodeficiency virus and genotype 3 hepatitis C virus co-infection: a report of three cases. Intern Med. 2019;58:797\u2013802.","journal-title":"Intern Med"},{"key":"1524_CR18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMoa1702417","volume":"378","author":"S Zeuzem","year":"2018","unstructured":"Zeuzem S, Foster GR, Wang S, et al. Glecaprevir-Pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 infection. N Engl J Med. 2018;378:354\u201369.","journal-title":"N Engl J Med"},{"key":"1524_CR19","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1046\/j.1351-8216.2003.00821.x","volume":"9","author":"R Kulkarni","year":"2003","unstructured":"Kulkarni R, Soucie JM, Evatt B, et al. Renal disease among males with haemophilia. Haemophilia. 2003;9:703\u201310.","journal-title":"Haemophilia"},{"key":"1524_CR20","first-page":"437","volume":"96","author":"JM Soucie","year":"2000","unstructured":"Soucie JM, Nuss R, Evatt B, et al. Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators. Blood. 2000;96:437\u201342.","journal-title":"Blood"},{"key":"1524_CR21","first-page":"687","volume":"124","author":"Y Segawa","year":"2015","unstructured":"Segawa Y, Ishida R, Tamagaki K. Hepatitis C virus-associated with glomerulonephritis. J Kyoto Pref Univ Med. 2015;124:687\u201395.","journal-title":"J Kyoto Pref Univ Med"},{"key":"1524_CR22","doi-asserted-by":"publisher","first-page":"678546","DOI":"10.3389\/fphar.2021.678546","volume":"12","author":"H Roguljic","year":"2021","unstructured":"Roguljic H, Nincevic V, Bojanic K, et al. Impact of DAA treatment on cardiovascular disease risk in chronic HCV infection: an update. Front Pharmacol. 2021;12:678546.","journal-title":"Front Pharmacol"},{"key":"1524_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1177\/2325957415614650","volume":"15","author":"R Kohli","year":"2016","unstructured":"Kohli R, Winston D, Sheehan H, et al. Cholesterol levels in HIV- and\/or HCV-infected drug users living in Argentina. J Int Assoc Provid AIDS Care. 2016;15:400\u20135.","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"1524_CR24","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1089\/aid.2015.0170","volume":"32","author":"K Townsend","year":"2016","unstructured":"Townsend K, Meissner EG, Sidharthan S, et al. Interferon-free treatment of hepatitis C virus in HIV\/hepatitis C virus-co-infected subjects results in increased serum low-density lipoprotein concentration. AIDS Res Hum Retroviruses. 2016;32:456\u201362.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"1524_CR25","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.2169\/internalmedicine.1514-18","volume":"58","author":"T Ichikawa","year":"2019","unstructured":"Ichikawa T, Miyaaki H, Miuma S, et al. Carotid intima-media thickness and small dense low-density lipoprotein cholesterol increase after one year of treatment with direct-acting antivirals in patients with hepatitis C virus infection. Intern Med. 2019;58:1209\u201315.","journal-title":"Intern Med"},{"key":"1524_CR26","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1111\/jgh.14741","volume":"34","author":"D Morihara","year":"2019","unstructured":"Morihara D, Ko YL, Shibata K, et al. IL28B gene polymorphism is correlated with changes in low-density lipoprotein cholesterol levels after clearance of hepatitis C virus using direct-acting antiviral treatment. J Gastroenterol Hepatol. 2019;34:2019\u201327.","journal-title":"J Gastroenterol Hepatol"},{"key":"1524_CR27","doi-asserted-by":"publisher","first-page":"10226","DOI":"10.3748\/wjg.v22.i46.10226","volume":"22","author":"MR Pedersen","year":"2016","unstructured":"Pedersen MR, Patel A, Backstedt D, et al. Genotype specific peripheral lipid profile changes with hepatitis C therapy. World J Gastroenterol. 2016;22:10226\u201331.","journal-title":"World J Gastroenterol"},{"key":"1524_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijid.2019.12.029","volume":"92","author":"PH Kuo","year":"2020","unstructured":"Kuo PH, Sun HY, Chuang YC, et al. Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir\/cobicistat\/emtricitabine\/tenofovir alafenamide. Int J Infect Dis. 2020;92:71\u20137.","journal-title":"Int J Infect Dis"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-021-01524-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-021-01524-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-021-01524-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T16:11:08Z","timestamp":1635610268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-021-01524-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1524"],"URL":"https:\/\/doi.org\/10.1007\/s12328-021-01524-1","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2021,10,19]]},"assertion":[{"value":"21 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Takayoshi Suga received research funding from MSD K.K.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights"}},{"value":"Informed consent was obtained from the patient for inclusion in the case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}